The agency cleared lab-based and point-of-care infectious disease and clinical chemistry tests as well as software for digital pathology.

Thermo Fisher announced it would close its Weaverville plant on Jan. 9. Some say federal research spending may have impacted ...

Heavy metal testing market is in a phase of robust expansion. Driven by a global consensus that 10 ppb is the new zero, and ...

Power Moves is a recurring series where we chart the comings and goings of talent across the region. Got a new hire, gig or promotion? Email us at philly@technical.ly. Philly companies and ...

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors has authorized the repurchase of $5 billion of shares of its common stock in ...

Thermo Fisher Scientific, already a big player in providing services to the biopharmaceutical industry, is adding to its technology capabilities with the $9 billion acquisition of clinical trial ...

Thermo Fisher Scientific is breaking out the big bills to score a clinical research treat. With $8.875 billion in cash, the life science giant is adding Clario Holdings to its goodie bag, the company ...

Oct 29 (Reuters) - Thermo Fisher (TMO.N), opens new tab said on Wednesday it would buy privately held data management company Clario for up to $9.4 billion, strengthening its clinical trial research ...

Notably, Clario centralizes clinical trial endpoint data from devices, sites and patients, allowing pharma and biotech companies to digitally collect, manage, and analyze evidence across all phases of ...

Thermo Fisher Scientific TMO1.74%increase; green up pointing triangle agreed to acquire endpoint data solutions provider Clario Holdings from a shareholder group for $8.88 billion in cash. The ...

(Reuters) - Thermo Fisher said on Wednesday it would buy privately held data management company Clario for up to $9.4 billion, strengthening its clinical trial research business amid a strong rebound ...